NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,497,000 | -11.2% | 110,820 | +18.1% | 0.01% | -7.7% |
| Q3 2021 | $1,685,000 | -16.0% | 93,800 | -19.7% | 0.01% | -13.3% |
| Q2 2021 | $2,006,000 | -77.5% | 116,871 | -73.8% | 0.02% | -77.6% |
| Q1 2021 | $8,918,000 | +410.2% | 445,922 | +333.6% | 0.07% | +415.4% |
| Q4 2020 | $1,748,000 | -87.3% | 102,831 | -87.6% | 0.01% | -89.2% |
| Q3 2020 | $13,774,000 | -33.6% | 830,262 | -7.4% | 0.12% | -34.8% |
| Q2 2020 | $20,755,000 | +3.2% | 896,172 | -20.4% | 0.18% | -18.6% |
| Q1 2020 | $20,103,000 | +39.8% | 1,126,206 | +69.0% | 0.23% | +113.2% |
| Q4 2019 | $14,384,000 | -0.5% | 666,400 | -16.1% | 0.11% | -6.2% |
| Q3 2019 | $14,461,000 | -52.9% | 793,906 | -8.0% | 0.11% | -51.3% |
| Q2 2019 | $30,710,000 | +10.3% | 863,129 | +4.2% | 0.23% | +17.2% |
| Q1 2019 | $27,833,000 | +6.5% | 828,350 | +4.1% | 0.20% | -6.2% |
| Q4 2018 | $26,144,000 | -67.0% | 795,389 | -38.7% | 0.21% | -58.6% |
| Q3 2018 | $79,144,000 | +48.4% | 1,298,286 | +18.8% | 0.51% | +34.9% |
| Q2 2018 | $53,342,000 | -25.7% | 1,092,395 | +61.6% | 0.38% | -27.7% |
| Q1 2018 | $71,838,000 | – | 676,058 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |